|
⚲
|
| Keyboard |
| Aeglea BioTherapeutics Inc
✚
|
|
|---|---|
| CIK # | 0001636282 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001636282] | |
| 10-Q | [0001636282] | |
| 3 | [0001636282] | |
| 4 | [0001636282] | |
| 5 | [0001636282] | |
| 8-K | [0001636282] | |
| D | [0001636282] | |
| SC 13D | [0001636282] | |
| SC 13G | [0001636282] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Spyre Therapeutics Inc SYRE
Stock Option (Right to Buy) · derivative
|
2026-03-03 | Option exercise | 2,500 | $0.00 | |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2026-03-03 | Sell | 200 | $41.66 | 8,332 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2026-03-03 | Option exercise | 2,500 | $14.50 | 36,250 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2026-03-03 | Sell | 2,300 | $40.56 | 93,288 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2026-03-02 | Sell | 5,900 | $41.73 | 246,207 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2026-03-02 | Sell | 9,100 | $42.49 | 386,659 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2026-02-02 | Sell | 957 | $31.82 | 30,452 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2026-02-02 | Sell | 14,043 | $32.87 | 461,593 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2026-01-21 | Other | 63,227 | $0.00 | |
|
Spyre Therapeutics Inc SYRE
Stock Option (Right to Buy) · derivative
|
2026-01-09 | Grant | 140,000 | $0.00 | |
|
Spyre Therapeutics Inc SYRE
Stock Option (Right to Buy) · derivative
|
2026-01-09 | Grant | 140,000 | $0.00 | |
|
Spyre Therapeutics Inc SYRE
Stock Option (Right to Buy) · derivative
|
2026-01-09 | Grant | 528,000 | $0.00 | |
|
Spyre Therapeutics Inc SYRE
Stock Option (Right to Buy) · derivative
|
2026-01-09 | Grant | 140,000 | $0.00 | |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2026-01-02 | Sell | 2,191 | $31.79 | 69,652 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2026-01-02 | Sell | 100 | $32.39 | 3,239 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2026-01-02 | Sell | 12,709 | $30.47 | 387,243 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2025-12-01 | Sell | 10,995 | $28.73 | 315,886 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2025-12-01 | Sell | 4,005 | $29.83 | 119,469 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2025-11-03 | Sell | 16,845 | $23.66 | 398,553 |
|
Spyre Therapeutics Inc SYRE
Common Stock
|
2025-11-03 | Sell | 28,155 | $23.13 | 651,225 |
| showing 20 of 200 most recent transactions | |||||